References
World Health Organization. https://www.who.int/data/gho/data/indicators/indicator-details/GHO/gho-ghe-ncd-mortality-rate (2019).
NCD Risk Factor Collaboration (NCD-RisC). Lancet 10304, 957–980 (2021).
World Health Organization. https://www.who.int/publications/i/item/9789240074323 (2023).
World Health Organization. https://www.who.int/publications-detail-redirect/9789290210054 (2022).
World Health Organization. https://www.who.int/southeastasia/publications/i/item/9789290210887 (2023).
World Health Organization. https://go.nature.com/3ue0gTL (2022).
World Health Organization. https://www.who.int/publications/i/item/WHO-NMH-PND-16.4 (2017).
World Health Organization. https://www.who.int/publications/i/item/9789240021105 (2021).
Kaur, P. et al. J. Hum. Hypertens. 37, 560–567 (2023).
Varghese, C. et al. BMJ 364, l327 (2019).
World Health Organization. https://www.who.int/publications/i/item/9789240077164 (2023).
World Health Organization. https://www.who.int/publications/i/item/9789240067233 (2022).
Acknowledgements
The authors thank participants in the Workshop for Implementing the WHO South-East Asia NCD Roadmap, 2022–2030, 12–15 June 2023, in Dhaka, Bangladesh, for providing valuable inputs in drafting the Dhaka Call to Action and calling upon national governments, health service providers, non-state actors and developmental partners to undertake actions as appropriate to their constituencies.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Joshi, P., Amin, M.R., Dorin, F.A. et al. The Dhaka Call to Action to accelerate the control of cardiovascular diseases in South-East Asia. Nat Med 30, 19–20 (2024). https://doi.org/10.1038/s41591-023-02678-w
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-023-02678-w
- Springer Nature America, Inc.